Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 11.61B 365M 312M 292M 267M 502M 34.88B 509M 3.45B 1.35B 17.52B 1.37B 1.34B 57.95B P/E 2026 *
10.2x
P/E 2027 * -
Enterprise Value 11.61B 365M 312M 292M 267M 502M 34.88B 509M 3.45B 1.35B 17.52B 1.37B 1.34B 57.95B EV / Sales 2026 *
2.73x
EV / Sales 2027 * 2.61x
Free-Float
47.64%
Yield 2026 *
5.87%
Yield 2027 * -
08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-04 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
24-11-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-09 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
1 week+2.24%
Current month+3.40%
1 month-1.44%
3 months+5.38%
6 months+1.11%
Current year-6.16%
1 week 132.5
Extreme 132.5
139.5
1 month 130.5
Extreme 130.5
147
Current year 122
Extreme 122
154
1 year 122
Extreme 122
182
3 years 122
Extreme 122
352.5
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.643305
432.08
Manager TitleAgeSince
Chief Executive Officer - 2010-01-31
Director of Finance/CFO - 2016-03-31
President - -
Director TitleAgeSince
Chairman - 2012-06-27
Director/Board Member - 2003-06-01
Director/Board Member 66 2012-06-27
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.24%-23.68%-60.64% 365M
+1.24%+0.40%-40.00%-6.71% 87.56B
-0.81%-3.10%-7.95%-19.76% 35.46B
+0.08%+0.07%+4.35%-18.06% 14.87B
+1.01%+8.10% - - 12.02B
+1.22%+4.44%-15.98%+705.65% 2.47B
-3.25%-4.60%-42.35%-59.35% 1.46B
-1.08%-2.34%+57.64%-6.23% 897M
-0.53%+0.81%+18.10%+10.39% 897M
-0.64%+0.75%-39.18%-19.54% 879M
Average -0.28%+0.69%-9.89%+58.42% 15.69B
Weighted average by Cap. +0.57%+0.18%-26.21%+0.43%

Financials

2026 *2027 *
Net sales 4.25B 134M 114M 107M 97.96M 184M 12.77B 186M 1.26B 493M 6.42B 501M 490M 21.23B 4.44B 139M 119M 112M 102M 192M 13.34B 195M 1.32B 515M 6.7B 524M 512M 22.17B
Net income 1.14B 35.86M 30.72M 28.74M 26.31M 49.38M 3.43B 50.03M 340M 132M 1.72B 135M 132M 5.7B -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
26-08-21 NT$137.00 0.00% 136,013
26-08-20 NT$137.00 +0.74% 264,932
26-08-19 NT$136.00 +1.87% 150,896
26-08-18 NT$133.50 -1.11% 190,404
26-08-17 NT$135.00 +0.75% 139,662
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
137.00TWD
Average target price
150.00TWD
Spread / Average Target
+9.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock